Quiron Hospital of Valencia will offer their patients an innovative test for early diagnosis of melanoma, “MRisk” , which determines the susceptibility of developing a melanoma by joint measurement of genetic risk, phenotypic risk and exogenous factors.

Descargar PDF

sistemas genómicos
Privacy Summary

This website uses cookies so that we can offer you the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our team understand which sections of the website you find most interesting and useful. You can access our privacy policy here